skip to main content
select
select
select
DateCaseTitleExpertiseCounsel
May 4, 2015 2015 FCA 116 Cobalt Pharmaceuticals Company v. Bayer Inc. We successfully represented Bayer in appeals from a decision of the Federal Court regarding patents covering oral contraceptives containing drospir...

Patents

Oct 1, 2014 Court File No. A-45-14 Takeda v. Apotex We represented Takeda on appeals from a section 8 damages action relating to pantoprozole (PANTOLOC®). The appeals were resolved prior to a hea...

Patents

May 7, 2014 2014 FC 436 Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Apotex Inc. and the Minister of Health The validity of Bayer’s key patent covering the oral contraceptives YASMIN® and YAZ® was upheld by the Federal Court.

Patents

Feb 14, 2014 2014 FC 149 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company - 2014 FC 149 This case involves an application for an order in the nature of prohibition to restrain the Minister of Health from issuing a Notice of Compliance ...

Patents

Dec 11, 2013 2013 FC 1237 Apotex Inc. v. Takeda Canada Inc. We represented Takeda in defending a damages case pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations.

Patents

Oct 22, 2013 2013 FC 1061 Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Cobalt Pharmaceuticals Company and the Minister of Health We represented Bayer and obtained a prohibition order against Cobalt’s generic version of Bayer’s YAZ® (drospirenone / ethinyl estr...

Patents

Apr 11, 2012 2012 FC 410 Alcon Canada Inc. v. Apotex Inc. We represented Alcon in a proceeding under the Patented Medicines (Notice of Compliance) Regulations relating to PATANOL.

Patents

May 12, 2010 2010 FC 42 Janssen-Ortho Inc. v. Canada (Health) Lindsay Neidrauer represented Janssen-Ortho and Alza Corporation in a proceeding under the Patented Medicines (Notice of Compliance) Regulations re...

Patents

Jun 22, 2009 2009 FCA 212 Janssen-Ortho Inc. v. Apotex Inc. Neil Belmore and Lindsay Neidrauer were successful in preventing Apotex from marketing a generic version of LEVAQUIN®.  This appeal involv...

Patents

Jun 17, 2008 2008 FC 744 Janssen-Ortho Inc. v. Apotex Inc. Neil Belmore and Lindsay Neidrauer successfully obtained a prohibition order preventing Apotex from launching a generic version of LEVAQUIN®.

Patents

Apr 8, 2008 2008 FC 454 Nycomed Canada Inc. v. Novopharm Ltd. This is a motion by the Respondent, Novopharm Limited (Novopharm), pursuant to section 6(5)(b) of the Patented Medicines Notice of Compliance Regul...

Patents

Mar 10, 2008 2008 FC 330 Nycomed GmbH v. Canada (Minister of Health) Neil Belmore and Lindsay Neidrauer successfully defended against a motion to dismiss a proceeding for a prohibition application in respect of PANTO...

Patents

Mar 6, 2008 2008 FC 308 Solvay Pharma Inc. v. Apotex Inc. Neil Belmore and Lindsay Neidrauer represented Solvay Pharma and Altana Pharma in an application for a prohibition order to prevent Apotex from mar...

Patents

Aug 23, 2007 2007 FCA 269 Janssen-Ortho Inc. v. Novopharm Ltd. Neil Belmore and Lindsay Neidrauer successfully represented Janssen-Ortho on this appeal from a motion to reconsider.

Patents

Jun 22, 2007 2007 FCA 243 Apotex Inc. v. Bayer AG Neil Belmore and Lindsay Neidrauer successfully represented Bayer on this appeal relating to CIPRO®.

Patents

Jun 7, 2007 2007 FCA 217 Janssen-Ortho Inc. v. Novopharm Ltd. Neil Belmore and Lindsay Neidrauer successfully represented Janssen-Ortho on this appeal from the trial decision finding that Novopharm’s cha...

Patents

Oct 3, 2005 2005 FC 1299 Pfizer Canada Inc. v. Novopharm Ltd. Lindsay Neidrauer successfully acted for Pfizer in respect of its ZITHROMAX® antibiotic and obtained a prohibition order against Novopharm&rsqu...

Patents

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy